Trial Profile
Non-interventional, retrospective, single-center study of teriflunomide in patients with treatment-naive, previously-treated multiple-sclerosis : A real world experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2016
Price :
$35
*
At a glance
- Drugs Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 17 Nov 2016 New trial record